Thalassemia trait in a girl with heterozygous hemoglobin E variant

Autor: Mata Fernández, A., Llovet Rodríguez, P., Soriano Balcázar, N., Lobo Samper, C., Torrado Carrión, R.A., Fernández Garrido, V., Martín Pedroche, E., Cuesta De Juan, S.

Publikováno v: In Clinica Chimica Acta 1 May 2024 558 Supplement 1

T183 A comparison study of the TRAB immunoassay between Snibe MAGLUMI and Roche Cobas

Autor: Cuesta De Juan, S., Garcia Ayuela, J., Torrado Carrion, R.A., Mata Fernadez, A., Soriano Balcazar, N., Perez Alonso, M., Santos-Ruiz Rodriguez-Arias, M., Siguin Gomez, A.

Publikováno v: In Clinica Chimica Acta 1 May 2022 530 Supplement 1:S142-S142

M307 A comparison study between MAGLUMI and Abbott ARCHITECT intact parathyroid hormone (PTH) assay

Autor: Cuesta De Juan, S., Garcia Ayuela, J., Mata Fernadez, A., Torrado Carrion, R.A., Martinez Sanchez, C., Piqueras Picon, R., Dacosta Galan, C., Garcia-Alcala Hernandez, M.

Publikováno v: In Clinica Chimica Acta 1 May 2022 530 Supplement 1:S46-S47

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.

Autor: Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Rodríguez-Abreu D; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Ortega AL; Medical Oncology Department, Hospital Universitario de Jaén, Jaén, Spain., Serrano G; Medical Oncology Department, Hospital Universiario Infanta Leonor, Madrid, Spain., Aguado C; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Franco F; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Gutierrez V; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain., López Vivanco G; Medical Oncology Department, Hospital Universitario Cruces, Barakaldo, Spain., Guirado M; Medical Oncology Department, Hospital General Universitario de Elche, Alicante, Spain., Benítez G; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Estival A; Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain., Calvo V; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jiménez B; Medical Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain., Arasanz H; Medical Oncology Department, Complejo Hospitalario Navarra-Navarrabiomeed, Pamplona, Spain., Coves J; Medical Oncology Department, Hospital Universitari Son LLàtzer, Palma de Mallorca, Spain., Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Massutí B; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Juan-Vidal O; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Collazo-Lorduy A; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Gozálvez CL; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain., Del Barco E; Medical Oncology Department, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Rosero A; Medical Oncology Department, Hospital Universitario Infanta Cristina, Madrid, Spain., Bosch-Barrerra J; Medical Oncology Department, Institut Català d'Oncologia, Girona, Spain., Moreno MA; Medical Oncology Department, Hospital Universitario de Puerto Real, Cádiz, Spain., Mielgo-Rubio X; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Villa JC; Medical Oncology Department, Hospital General Universitario Ciudad Real, Ciudad Real, Spain., López-Martin A; Medical Oncology Department, Hospital Universitario Severo Ochoa, Madrid, Spain., Córdoba JF; Medical Oncology Department, Hospital Universitario Arnau de Vilanova, Lleida, Spain., de Asís Aparisi F; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Zafra M; Medical Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain., Mosquera J; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Pérez Altozano J; Medical Oncology Department, Hospital Virgen de los Lirios, Alicante, Spain., Nadal E; Medical Oncology Department, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Catot S; Medical Oncology Department, Altaia, Xarxa Assistencial Universitaria Manresa, Barcelona, Spain., Balsalobre J; Medical Oncology Department, Hospital General Universitario Santa Lucia, Cartagena, Murcia, Spain., de Portugal T; Medical Oncology Department, Complejo Hospitalario de Zamora, Zamora, Spain., Martín P; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Cuesta de Juan S; Laboratorio Central, Eurofins Megalab, Madrid, Spain., Cobo M; Medical Oncology Department, Hospital Universitario Regional de Málaga, Málaga, Spain.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2022 Jan; Vol. 11 (1), pp. 53-63.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.